Loading…
CIK 0001037353 • 6 13F filings • May 6, 2025 – Aug 3, 2026
Import this data to Google Sheets with:
=jivedata("pathway-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ARCELLX, INC. | COMMON STOCK | $4.2M | 20.6% | 51,051 SH | New |
| CRISPR THERAPEUTICS AG | NAMEN AKT | $3.2M | 15.9% | 50,049 SH | New |
| GOODRX HOLDINGS, INC. | COM CL A | $4.2M | 20.5% | 986,158 SH | New |
| HIMS & HERS HEALTH, INC. | COM CL A | $6.8M | 33.3% | 119,279 SH | New |
| NEUEHEALTH INC | COM NEW | $75K | 0.4% | 11,201 SH | New |
| NU HOLDINGS LTD. | ORD SHS CL A | $945K | 4.6% | 59,010 SH | New |
| PDD HOLDINGS INC. | SPONSORED ADS | $951K | 4.7% | 7,197 SH | New |
| 13F-HR |
| 0001214659-26-009446 |
| $23.9M |
| View |
| Aug 4, 2025 | Q2 2025 | 13F-HR | 0001214659-25-011423 | $91.3M | View |
| May 1, 2026 | Q1 2026 | 13F-HR | 0001214659-26-005375 | $4.3M | View |
| May 6, 2025 | Q1 2025 | 13F-HR | 0001214659-25-006988 | $17.3M | View |